Charles Ryan

Charles Ryan

PresidentatIRulya Therapeutics· In proxies 2023–2025

Pay in FY2025+28% from the year before · IRulya Therapeutics stock +79.1% the same year

Charles Ryan was paid $1.1M in FY2025 (Dec), up 28%. IRulya Therapeutics stock rose 79.1% that year.

Pay$100 in the stock at the end of FY22 → $526
Pay is from the Summary Compensation Table of each IRulya Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. IRulya TherapeuticsPublic company · 3 yr
    • President2023 – Present · 3 yrStock in role -72%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?